US Delivers 1,25,000 Remdesivir Vials To India, 4th Covid Relief Shipment

Remdesivir is approved in India for restricted emergency use for the treatment of suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe disease.

India received 1,25,000 vials of antiviral drug Remdesivir, the fourth Covid relief shipment, from the United States on Sunday as New Delhi fights a deadly second wave that has strained its healthcare system. The American people stand united with India in the fight against COVID-19! Today, 125,000 vials of the antiviral drug Remdesivir arrived from the U.S. -the 4th relief shipment- and there are more life-saving supplies on the way. Thanks @USAID and @HHSGov for coord! #USIndiaDostipic.twitter.com/Fz6mxmtY7P This is the fourth straight day that India has recorded over 3,000 deaths due to Covid. Hospitals are overburdened and there is dire shortage of key drugs and oxygen supplies. "The American people stand united with India in the fight against COVID-19! Today, 125,000 vials of the antiviral drug Remdesivir arrived from the U.S. -the 4th relief shipment- and there are more life-saving supplies on the way," tweeted the US Embassy in India, adding the #USIndiaDosti.